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Symplekin and xGLD-2 Are Required for
CPEB-Mediated Cytoplasmic Polyadenylation
ment binding protein (CPEB; Paris et al., 1991; Hake
and Richter, 1994), which, in response to progesterone
stimulation, is activated through aurora A-catalyzed
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phosphorylation (Mendez et al., 2000a). Phospho-CPEBUniversity of Massachusetts Medical School
has an enhanced affinity for cleavage and polyadenyla-Worcester, Massachusetts 01605
tion specificity factor (CPSF; Mendez et al., 2000a),2 Department of Biological Sciences
which may help stabilize its association with the AAUColumbia University
AAA. CPSF in turn may recruit a poly(A) polymerase toNew York, New York 10027
the mRNA (Mendez and Richter, 2001).
The translational repression of CPE-containing mRNAs
in oocytes and their activation during maturation is con-Summary
trolled by maskin, a CPEB binding protein (Stebbins-
Boaz et al., 1999). Maskin also interacts with the capCytoplasmic polyadenylation-induced mRNA transla-
binding eIF4E; this association precludes the formationtion is a hallmark of early animal development. In Xe-
of an eIF4E-eIF4G complex that is necessary for initia-nopus oocytes, where the molecular mechanism has
tion. When CPE-containing RNAs undergo polyadenyla-been defined, the core factors that control this process
tion, poly(A) binding protein (PABP) is recruited to theinclude CPEB, an RNA binding protein whose associa-
newly elongated poly(A) tail where it has an additionaltion with the CPE specifies which mRNAs undergo poly-
interaction with eIF4G (cf. also Wells et al. [1998], Kah-adenylation; CPSF, a multifactor complex that interacts
vejian et al. [2001]). PABP helps eIF4G displace maskinwith the near-ubiquitous polyadenylation hexanucleo-
from eIF4E, thereby stimulating translation (Cao andtide AAUAAA; and maskin, a CPEB and eIF4E binding
Richter, 2002).protein whose regulation of initiation is governed by
Maskin was initially identified as one of a few proteinspoly(A) tail length. Here, we define two new factors
that coimmunoprecipitated with CPEB (Stebbins-Boazthat are essential for polyadenylation. The first is sym-
et al., 1999). One of the other proteins was identifiedplekin, a CPEB and CPSF binding protein that serves
through a short peptide that had no match in the data-as a scaffold upon which regulatory factors are as-
bases. A recent BLAST search, however, revealed thissembled. The second is xGLD-2, an unusual poly(A)
protein to be the Xenopus homolog of symplekin, whosepolymerase that is anchored to CPEB and CPSF even
counterpart in mammalian cells interacts with CPSF andbefore polyadenylation begins. The identification of
cleavage stimulatory factor (CstF), components of thethese factors has broad implications for biological
nuclear pre-mRNA cleavage and polyadenylation ma-process that employ polyadenylation-regulated trans-
chinery (Takagaki and Manley, 2000; Hofmann et al.,lation, such as gametogenesis, cell cycle progression,
2002). In yeast, the apparent symplekin homolog Pta1and synaptic plasticity.
is necessary for both cleavage and polyadenylation of
nuclear pre-mRNA (Preker et al., 1997; Zhao et al., 1999).
Introduction In spite of these observations, the biochemical function
of symplekin is unknown, although it has been sug-
Regulated mRNA translation is one hallmark of early gested to act as a molecular platform upon which the
animal development. Although there are a number of nuclear polyadenylation machinery is assembled (Taka-
mechanisms by which translation is controlled, one that gaki and Manley, 2000).
is used in oocytes and embryos is the modulation of In this study, we demonstrate that symplekin resides
poly(A) tail length. Studies from both vertebrate and in a cytoplasmic polyadenylation complex and directly
invertebrate material have demonstrated that the poly(A) contacts both CPSF and CPEB. The injection of sym-
tails of certain mRNAs lengthen or shorten as develop- plekin antibody into oocytes or its addition to egg ex-
ment proceeds; in general, poly(A) tail elongation pro- tracts inhibited polyadenylation. Immunodepletion of
motes translational activation, while poly(A) removal is symplekin from egg extracts also disrupted polyadenyl-
associated with translational silencing (Richter, 2000). ation; however, the introduction of recombinant sym-
In Xenopus oocytes, several dormant mRNAs such as plekin to the depleted extracts failed to restore polyad-
those encoding mos and cyclin B1 have short poly(A) enylation. Because symplekin immunodepletion also
tails 20 bases in length. When the oocytes are stimu- resulted in the loss of CPEB and CPSF from the extracts,
lated to reenter the meiotic divisions, the tails on these this may explain why supplemental symplekin did not
mRNAs elongate to100–150 nucleotides, and transla- restore polyadenylation. Surprisingly, complementation
tion ensues. Cytoplasmic polyadenylation requires two of the depleted extract with symplekin, CPSF, and CPEB
3 UTR elements, AAUAAA and UUUUUAU (consensus), still did not stimulate polyadenylation. These observa-
the cytoplasmic polyadenylation element (CPE). The tions suggested that yet another essential polyadenyla-
CPE is bound by the cytoplasmic polyadenylation ele- tion factor was codepleted with symplekin. An analysis
of the factors associated with the symplekin-containing
complex revealed the presence of the Xenopus homolog*Correspondence: joel.richter@umassmed.edu
of GLD-2, a member of an unusual family of nucleotidyl-3 Present address: Department of Chemistry, City College of New
York, New York, New York 10031. transferases identified in S. pombe (Saitoh et al., 2002),
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S. cerevisiae (Read et al., 2002), and C. elegans (Wang mature) oocytes, despite the fact that 80% of the
CPEB is destroyed during maturation (Mendez et al.,et al., 2002) that has poly(A) polymerase activity. Most
importantly, supplemental Xenopus GLD-2 (xGLD-2), 2002) (Figure 1B, compare the amounts of CPEB in lanes
lane 1 and 2 with those in lanes 4 and 6). These resultstogether with symplekin, CPEB, and CPSF, restored
polyadenylation to the symplekin-depleted extracts. suggest that the symplekin bound CPEB might be pro-
tected from destruction upon maturation and that it isMoreover, the immunodepleted symplekin-associated
complex was able to polyadenylate RNA in an extraordi- this pool of CPEB that is active in polyadenylation.
To investigate which interactions among CPEB,narily robust manner. Finally, xGLD-2 is anchored to the
cytoplasmic polyadenylation complex through direct in- CPSF, and symplekin are direct, CPEB and symplekin
were expressed in E. coli as fusion proteins with S tagteractions with both CPEB and CPSF in polyadenylation-
deficient oocyte extracts as well as in polyadenylation- on their amino termini. The S tag is a small peptide that
has a strong binding affinity for S protein, which is affixedproficient egg extracts. These results not only suggest
a revised model for how cytoplasmic polyadenylation is to agarose beads (Novagen). Thus, S-tagged CPEB and
symplekin were immobilized on beads and used as affin-regulated but have ramifications for cell cycle progres-
sion and neuronal synaptic plasticity, and other biologi- ity matrices to test for the binding of 35S-methonine-
labeled CPEB, the 160 kDa subunit of CPSF (CPSF160),cal processes that employ this form of translational
control. or symplekin. CPEB but not maskin, a negative control,
was retained on an S-tagged-symplekin column (Figure
1C). Conversely, symplekin (two forms are produced, asResults
observed by Takagaki and Manley [2000]) was retained
on an S-tagged CPEB column, as was CPSF160 (FigureSymplekin Is a Component of the Cytoplasmic
1D). In no case were proteins retained on an emptyPolyadenylation Machinery
column (i.e., S protein-agarose). These results provideFollowing 35S-methionine labeling of Xenopus oocytes,
evidence that CPEB, CPSF, and symplekin are capableStebbins-Boaz et al. (1999) used CPEB antibody coim-
of directly interacting with one another.munoprecipitation to identify maskin as an interacting
protein. A scale up of the CPEB coimmunoprecipitation
Symplekin Mediates Cytoplasmic Polyadenylationprocedure yielded sufficient material for mass spec-
We have performed two sets of experiments to addresstrometry not only of maskin but also of a few other
whether symplekin is required for CPE-mediated poly-proteins. One of these proteins was identified through
adenylation. First, symplekin antibody, or a control IgG,a single short peptide that until recently had no match
was injected into Xenopus oocytes that were also in-in the databases. However, a new BLAST search has
jected with reporter RNAs that lacked or contained aidentified this protein as the Xenopus homolog of sym-
CPE. The oocytes were then induced to mature withplekin. Mammalian symplekin associates with CstF and
progesterone; the RNA was isolated from the oocytesCPSF, two factors involved in nuclear pre-mRNA cleav-
and scored for polyadenylation by gel electrophoresis.age and polyadenylation (Takagaki and Manley, 2000;
Figure 2A shows that, while progesterone stimulatedHofmann et al., 2002). A related protein in yeast, PTA1,
robust polyadenylation of CPE-containing RNA evenis a component of the polyadenylation machinery (Zhao
when IgG was injected (lanes 4 and 6), there was aet al., 1999). In spite of these observations, however,
dramatic reduction in both the length of the poly(A) tailthe molecular function of symplekin in polyadenylation
and the overall extent of polyadenylation when sym-is not known.
plekin antibody was injected (lane 6). As expected, theTo verify the interaction between CPEB and sym-
reduction of polyadenylation by symplekin antibody wasplekin, we performed an additional coimmunoprecipita-
accompanied by the inhibition of progesterone-inducedtion from Xenopus oocytes with CPEB antibody as well
translation of mos mRNA, which serves as a marker foras a nonspecific IgG, which served as a control. The
translation of CPE-containing mRNA (Figure 2B, lane 4).Western blot in Figure 1A shows that symplekin was
Symplekin antibody, or control IgG, was also addeddetected only when CPEB antibody was used for the
to polyadenylation-competent egg extracts (Hake andcoimmunoprecipitation (note that RNase A was included
Richter, 1994; Stebbins-Boaz et al., 1996). Only the sym-in all protein coimmunoprecipitation buffers). To confirm
plekin antibody ablated the polyadenylation of CPE-this result, mRNA encoding myc-tagged CPEB was in-
containing RNA in a dose-dependent manner (Figurejected into oocytes and subjected to myc antibody
2C). These data indicate that symplekin mediates poly-coimmunoprecipitation. Compared to noninjected oo-
adenylation both in living cells and in cell lysates.cytes, from which no immunoprecipitated proteins were
detected, both myc-CPEB and symplekin were found in
the immunoprecipitates from the mRNA-injected oo- Immunodepletion and Replacement of Symplekin:
Ablation of Polyadenylationcytes. In a reciprocal experiment, endogenous CPEB
but not mos, a negative control, was coprecipitated with but Not Restoration
In a second set of experiments, we have sought to immu-symplekin antibody (Figure 1B). In addition, CPSF was
also coprecipitated symplekin, an observation made by nodeplete symplekin from egg extracts; if this procedure
destroyed polyadenylation, as expected, then a restora-Hofmann et al. (2002) as well, indicating that CPEB,
symplekin, and CPSF might all reside in a common com- tion of polyadenylation by replenishment with recombi-
nant protein would be a clear demonstration of its impor-plex. Interestingly, a coimmunoprecipitation with sym-
plekin antibody from mature oocytes pulled down tance in this process. Figure 3A shows that, while mock
immunodepletions with two different control IgGs hadroughly the same amount of CPEB as from control (im-
Symplekin, xGLD-2, and CPEB
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Figure 1. Interactions among CPEB, Symplekin, and CPSF
(A) Extracts from stage VI Xenopus oocytes were subjected to immunoprecipitation with CPEB antibody or a nonspecific IgG that served as
a control (NB, all protein coimmunoprecipitation buffers contained RNase A). Western blots of the precipitated proteins were probed for
symplekin and CPEB. Some oocytes were also injected with mRNA encoding myc-CPEB; myc antibody immunoprecipitates were probed for
the myc epitope and symplekin, as were untreated extracts.
(B) Extracts from oocytes that had been incubated in the absence or presence of progesterone were subject to immunoprecipitation with
symplekin antibody or control IgG. Western blots of both the immunodepleted extracts and the immunoprecipitated complexes were probed
for symplekin, CPSF100, CPEB, and, as a negative control, mos.
(C) mRNAs encoding maskin and CPEB were translated in a reticulocyte lysate in the presence of 35S-methionine and applied to columns of
S protein-agarose alone or S protein-agarose containing S-tagged recombinant symplekin. The columns were washed and the bound material
analyzed by SDS-PAGE.
(D) 35S-methionine-labeled CPSF160 and symplekin were applied to columns containing S protein or S protein-CPEB and analyzed as in (C).
Note that two proteins are produced by in vitro translation of symplekin mRNA; the faster migrating form could be due to downstream initiation,
early termination, or protein breakdown.
no effect on polyadenylation (lanes 3 and 5), symplekin and it too was clearly evident on the antibody beads. A
nonspecific band that reacted with the CPSF100 anti-antibody completely destroyed polyadenylation activity
of the extract (lane 6). Unfortunately, polyadenylation body was neither depleted with the symplekin antibody
nor evident on the antibody beads and thus serves asactivity was not restored upon addition of a purified
E. coli-expressed GST-symplekin fusion protein (lane 7). a control for the immunodepletion. Finally, almost all the
CPEB was codepleted with the symplekin antibody, andWhile there could be a number of reasons for the lack of
restored polyadenylation with supplemental symplekin, it too was clearly detected on the antibody beads. (Note
that, in a reciprocal experiment with CPEB antibody,the protein-protein interaction data presented in Figure
1 made it seem likely that it was due to the codepletion only25% of the symplekin was coimmunoprecipitated
[data not shown].) This result is not surprising, given thatof CPEB, CPSF, and perhaps other proteins. To assess
this possibility, the depleted extract as well as the anti- symplekin is both nuclear and cytoplasmic in oocytes
(Hofmann et al., 2002), while CPEB is exclusively cyto-body-containing beads were probed for the presence
of these proteins (Figure 3B). Nearly 90% of the sym- plasmic (Hake and Richter, 1994). Thus, the failure of
recombinant symplekin to restore polyadenylation seemedplekin was depleted from the extract and was clearly
evident on the antibody beads. Virtually all the CPSF likely due to the codepletion of these other proteins. To
test this, symplekin antibody-depleted extracts, which100 was also depleted with the symplekin antibody,
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Identification of xGLD-2 as a Xenopus
Poly(A) Polymerase
There are several isoforms of poly(A) polymerase that
arise from alternative splicing (Zhao and Manley, 1996),
at least some of which are present in Xenopus oocytes
(Gebauer and Richter, 1995; Ballantyne et al., 1995).
However, poly(A) polymerase becomes phosphorylated,
most likely by cdk1 (Colgan et al., 1998), as cells, includ-
ing oocytes, enter M phase (Ballantyne et al., 1995; Col-
gan et al., 1996). These phosphorylation events inactivate
the enzyme (Colgan et al., 1996), which seems curious,
given that oocyte maturation is precisely the time at which
cytoplasmic polyadenylation is observed. These appar-
ently conflicting observations suggest that there might
be a noncanonical poly(A) polymerase that is not inacti-
vated during entry into M phase and that mediates cyto-
plasmic polyadenylation. This possibility led us to con-
sider three newly identified but related proteins that
have poly(A) polymerase activity: Cid1 and Cid13 in
S. pombe (Saitoh et al., 2002; Read et al., 2002), Trf4 in
S. cerevisiae (Saitoh et al., 2002), and GLD-2 in C. ele-
gans (Wang et al., 2002), which are all members of a
terminal nucleotidyltransferase superfamily (Kwak et al.,
2004). Using the Cid13 sequence in a BLAST search,
we identified a Xenopus-expressed sequence tag (EST)
that was 32% identical and 53% similar over 198 amino
acids. Subsequent searches with the EST identified
overlapping fragments that, when pieced together,
yielded a complete open reading frame (ORF). A full-
length ORF was obtained by RT-PCR from Xenopus
oocyte RNA, and a subsequent BLAST search demon-
strated that, while the Xenopus protein had a region that
was 47% similar to Cid13, it was more similar (54%) to
C. elegans GLD-2 (Figure 4A; Wang et al., 2002). Like
C. elegans GLD-2, the Xenopus protein contains a con-
sensus DNA polymerase -like nucleotidyltransferase
domain and a PAP/25A-associated domain (a region
somewhat conserved in conventional poly[A] polymer-
ases, Figure 4A). However, unlike canonical poly(A) poly-
merase, no member of the Cid13/Cid1/GLD-2 family ofFigure 2. Symplekin Is Required for Cytoplasmic Polyadenylation
polymerases contains an RNA binding domain. Re-(A) Oocytes were injected with symplekin antibody or a control IgG
and incubated for 12–16 hr. A radiolabeled RNA probe containing cently, mouse (mGLD-2) and human GLD-2 (hGLD-2)
or lacking a CPE was injected and the oocytes further incubated in proteins have been described (Kwak et al., 2004); be-
the absence or presence of progesterone. The RNA was isolated cause these proteins are most homologous to the Xeno-
and resolved on a 6% denaturing gel.
pus protein described here (60% identical and 72% simi-(B) Oocytes injected as in (A) were analyzed for symplekin and mos
lar), we now refer to it as xGLD-2. Within an200 aminoexpression on Western blots.
(C) Egg extracts were mixed with increasing amounts of IgG or acid region that contains the catalytic domain, the iden-
symplekin antibody and then primed with radiolabeled RNA probes tity of xGLD-2 with the mammalian proteins rises to 80%
containing or lacking a CPE. The RNA was analyzed as in (A). (89%–90% similarity) and with the C. elegans protein to
43% (62% similarity) (Figure 4A and data not shown).
To initiate studies on xGLD-2, it was expressed in E. coli,were almost completely devoid of symplekin, CPSF, and
purified, and used to generate antibody. Immunostain-CPEB (Figure 3C), were supplemented not only with
ing of a Xenopus cell line (XTC) showed xGLD-2 is cyto-recombinant symplekin but also with recombinant CPEB
plasmic (Figure 4B), which is also the case with otherand partially purified HeLa cell CPSF. However, the addi-
members of this family of enzymes. While we were ini-tion of these proteins still failed to rescue polyadenyla-
tially unable to detect XGLD-2 in oocytes by Westerntion activity (Figure 3D). While there were a number of
blotting (see below), overexpressed protein did promoteplausible explanations for this lack of reconstituted poly-
polyadenylation in oocytes even in the absence of pro-adenylation, we considered the most likely one to be
gesterone. In contrast, an xGLD-2 containing an inacti-the codepletion of yet another protein. One other protein
vating D242A mutation in the catalytic domain (Kwak etthat certainly is necessary for polyadenylation is poly(A)
polymerase. al., 2004) elicited no response (Figure 4C).
Symplekin, xGLD-2, and CPEB
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Figure 3. Immunodepletion of Symplekin from Extracts Inhibits Polyadenylation
(A) Egg extracts were subjected to immunodepletion with symplekin antibody or two different control IgG antibodies. Some of the depleted
extracts were supplemented with recombinant symplekin and then primed with CPE-containing RNA for an analysis of polyadenylation activity.
(B) Western blots of symplekin antibody-depleted extracts as well as the antibody-containing beads were probed for symplekin, CPSF100,
and CPEB. A nonspecific band was recognized by the CPSF100 antibody.
(C) Extracts depleted with symplekin antibody or control IgG were probed for symplekin, CPSF100, and CPEB.
(D) The same extracts as those shown in (C) were supplemented with recombinant symplekin, symplekin plus recombinant CPEB, or these
two proteins plus CPSF. The extracts were primed with CPE-containing RNA and examined for polyadenylation.
xGLD-2 Is a Component of the Cytoplasmic To address whether xGLD-2 is involved with cyto-
plasmic polyadenylation, egg extracts were again sub-Polyadenylation Complex
Based on the results in Figures 1–3, as well as the sug- jected to symplekin antibody immunodepletion, which
as before removed most of the symplekin and CPSF.gested role of symplekin in nuclear polyadenylation (Ta-
kagaki and Manley, 2000), we surmised that symplekin xGLD-2 was not detected in the extract of total protein
but was clearly concentrated on the antibody beadsis a scaffold protein to which other components of the
cytoplasmic polaydenylation machinery are attached. If (Figure 5B). The extract was supplemented with CPSF,
CPEB, and symplekin as before, or these proteins plustrue, a symplekin coimmunoprecipitate might be the
best source to identify xGLD-2. Consequently, sym- either wild-type (WT) xGLD-2 or xGLD-2 that contained
the inactivating D242A mutation (Figure 5C). Strikingly,plekin was immunodepleted from oocyte extracts as
before, and the antibody beads were probed not only wild-type xGLD-2 but not D242A xGLD-2 restored partial
polyadenylation activity to the extract. xGLD-2 alsofor symplekin, CPSF100, and CPEB but for xGLD-2 as
well (Figure 5A). While the presence of symplekin, mildly stimulated polyadenylation when added to a sym-
plekin-depleted extract, which was probably due to theCPSF100, and CPEB on the beads was expected, we
were surprised to detect xGLD-2 because oocyte ex- approximately 10% of symplekin (as well as CPEB and
CPSF) that remained in the extract.tracts do not polyadenylate RNA, and thus we would
not expect it to be associated with the polyadenylation We also added substrate RNA to the complex of pro-
teins concentrated on the symplekin antibody beads,machinery at this time. An identical symplekin immuno-
depletion from mature, polyadenylation-proficient egg which directed the synthesis of an enormously long
poly(A) tail approaching 1500 bases in length (Figureextracts revealed the same spectrum of proteins in equal
ratios as in oocyte extracts (Figure 5A). These experi- 5D). This poly(A) tail is much longer than that observed
in the unfractionated extract, which is150 bases (lanements reveal two important observations: that xGLD-2
resides in a complex containing other components of 2), suggesting that a regulator of poly(A) tail length was
not coimmunoprecipitated with symplekin-containingthe cytoplasmic polyadenylation machinery and that it
is present in the complex even in the absence of polyad- complex.
To address the specificity of xGLD-2 activity, WT orenylation.
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Figure 4. Identification of a Novel Xenopus Cytoplasmic Poly(A) Polymerase
(A) Representation of the 509 amino acid Xenopus GLD-2 (xGLD-2) protein, indicating the catalytic domain with a flanking conserved central
domain region as well as the PAP/25A (polyA) polymerase) conserved domain and the nucleotidyltransferase domain. An alignment generated
from ClustalW analysis of related GLD-2 sequences from several animals shows the conserved nucleotidyltransferase domain from C. elegans
(ceGLD-2), human (hsGLD-2), mouse (mmGLD-2), and Xenopus (xGLD-2).
(B) Immunostaining of Xenopus XTC cells shows the cytoplasmic localization of xGLD-2. The cells were also immunostained for -tubulin
and costained with DAPI.
(C) Oocytes injected with mRNA encoding WT or catalytically inactive (D242A) XGLD-2 were also injected with CPE-containing RNA. Some
oocytes were further treated with progesterone before being analyzed for polyadenylation.
D242A mutant proteins were added to symplekin anti- pleted extracts, followed by incubation with CPE-lack-
ing or CPE-containing RNA. While the CPE-lacking RNAbody-depleted extracts that were supplemented with
CPEB, CPSF, and symplekin. This mixture was then was not polyadenylated in the extract alone and mini-
mally polyadenylated (i.e, 25 residues) in the extractincubated with RNA probes that lacked or contained a
CPE. While the D242A mutant had no ability to restore plus WT xGLD-2 (Figure 5F, compare lanes 3 and 4),
the CPE-containing RNA was strongly polyadenylatedpolyadenylation activity to the depleted extracts (Figure
5E, lanes 4 and 8), the WT GLD-2 stimulated polyadenyl- in the extract and even more so when xGLD-2 was added
(compare lanes 6 and 7). In no case did the D242Aation of both RNAs (lanes 3 and 7). However, the polyad-
enylation of the CPE-containing RNA was more robust; xGLD-2 mutant stimulate polyadenylation. Finally, we
added xGLD-2 to extracts and tested the polyadenyla-it gained a mean tail length of 70 residues, while the
CPE-lacking RNA gained a mean tail length of25 resi- tion of an “information-free” RNA derived from polylinker
sequence, an RNA containing only an AAUAAA, or andues. Because about 25 adenosine residues are neces-
sary for an interaction with poly(A) binding protein RNA containing both a CPE and an AAUAAA. The poly-
linker and AAUAAA-containing RNAs gained only short(PABP) (Jacobson, 1996), which is essential for promot-
ing CPEB-dependent translation in oocytes (Cao and poly(A) tails of 10 nucleotides, which, as noted pre-
viously, is very unlikely to stimulate translation. On theRichter, 2002), a “productive” polyadenylation that stim-
ulates translation would require a poly(A) tail of about other hand, the CPE and AAUAAA-containing RNA
gained a tail of greater than 50 nucleotides, whichthis length. Consequently, we infer that only poly(A) tails
that are at least this long are likely to be biologically sig- would likely stimulate translation. These results show
that, while xGLD-2 can stimulate polyadenylation ofnificant.
We also added WT and mutant xGLD-2 to nonde- CPE-lacking RNA, its stimulation of CPE-containing
Symplekin, xGLD-2, and CPEB
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Figure 5. xGLD-2 Interacts with the Cytoplasmic Polyadenylation Machinery and Promotes Polyadenylation
(A) Extracts prepared from control or progesterone-matured oocytes were subject to immunodepletion with symplekin antibody or control
IgG. Western blots of the antibody-containing beads were probed for symplekin, CPSF100, CPEB, and xGLD-2.
(B) Extracts depleted with symplekin antibody or control IgG as well as the antibody-containing beads were probed for symplekin, CPSF100,
and xGLD-2.
(C) IgG and symplekin antibody-depleted extracts were supplemented with CPSF, symplekin, CPEB, and WT xGLD-2 or a xGLD-2 with a
D242A substitution in the catalytic domain. The extracts were then primed with CPE-containing RNA and analyzed for polyadenylation.
(D) Antibody-containing beads from symplekin-depleted or IgG-depleted extracts were washed and mixed with CPE RNA, ATP, and PAP
buffer and incubated for 1.5 hr. The RNA was then analyzed for polyadenylation, as was RNA from an undepleted extract.
(E) Symplekin and IgG-depleted extracts were supplemented with a mixture of CPSF, symplekin, and CPEB or a mixture of these proteins
plus either WT xGLD-2 or a mutant xGLD-2 with a D242A mutation in the catalytic domain. The extracts were then analyzed for polyadenylation.
(F) Untreated extracts were supplemented with WT or D242A xGLD-2 protein and analyzed for polyadenylation of CPE-lacking or CPE-
containing RNA.
(G) Untreated extracts were supplemented with WT xGLD-2 and analyzed for polyadenylation of RNA derived from a polylinker sequence (i.e.,
information-free), RNA containing an AAUAAA but lacking a CPE, or RNA containing both an AAUAAA and CPE.
RNA is much stronger. We surmise that a surfeit of umn to any appreciable extent. Thus, CPEB and CPSF
probably act in concert to anchor xGLD-2 to the cyto-xGLD-2 in the supplemented extract induced nonspe-
plasmic polyadenylation complex.cific polyadenylation of the CPE-lacking RNA.
Soon after oocytes are induced to mature with proges-
terone, Aurora A catalyzes CPEB phosphorylation on
xGLD-2 Is Anchored to Polyadenylation serine 174, an event whose importance is underscored
Machinery through CPEB and CPSF by the observations that (1) CPEB with an S174A muta-
In C. elegans, the interaction of GLD-2 with GLD-3, a tion prevents CPE-dependent polyadenylation and trans-
sequence-specific RNA binding protein homologous to lation when oocytes are treated with progesterone, and
Drosophila Bicaudal-C, dictates which mRNAs undergo (2) CPEB with an S174D mutation stimulates CPE-
polyadenylation (Wang et al., 2002). By analogy, xGLD-2 dependent polyadenylation and translation in untreated
would also presumably interact with a sequence-spe- oocytes (Mendez et al., 2000a). Serine 174 phosphoryla-
cific RNA binding protein, in this case possibly CPEB. tion also enhances the affinity of CPEB for CPSF, sug-
Alternatively, perhaps CPSF, anchored to CPE-con- gesting that stable binding of these factors is important
taining RNA through CPEB, would make direct contact for polyadenylation (Mendez et al., 2000b). To determine
with XGLD-2. To distinguish between these possibilities, whether S174 phosphorylation also modifies the inter-
xGLD-2, or GST as a control, was expressed in E. coli action between CPEB and xGLD-2, reticulocyte-syn-
as a fusion protein with S tag and immobilized on S thesized CPEB proteins containing S174A and S174D
protein-agarose. In vitro-synthesized and 35S-metho- mutations were applied to S protein-agarose beads con-
nine-labeled CPSF160, CPEB, or symplekin (short and taining S-tagged xGLD-2. CPEB containing S174D was
long forms as in Figure 1) was applied to the agarose employed not only because this mutation faithfully mim-
beads, which were then washed extensively before elu- ics phospho-S174 but also because it was unlikely that
tion with buffer containing 150 mM KCl, 250 mM KCl, an in vitro Aurora A kinase reaction would phosphorylate
or SDS (Figure 6A). Interestingly, both CPEB and CPSF all of CPEB S174. Figure 6B shows that CPEB with
but not symplekin strongly interacted with xGLD-2 and S174D had a 2-fold greater affinity for xGLD-2 than
were not eluted from the column until SDS was applied. CPEB with S174A (the S174A CPEB was used in this
comparison to avoid a possible S174 phosphorylationNone of the proteins bound to the GST-containing col-
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tions with both CPEB and CPSF (Figure 6C). These new
results have a number of important implications for the
control of polyadenylation, not only in oocytes but in
cycling somatic cells and in neurons as well.
While symplekin was first identified as a protein asso-
ciated with the tight junctions of polarized epithelial cells
(Keon et al., 1996), it was subsequently shown to interact
with CPSF and CstF (Takagaki and Manley, 2000; Hof-
mann et al., 2002) and to be necessary for nuclear pre-
mRNA polyadenylation (Zhao et al., 1999; Xing et al.,
2004). Takagaki and Manley (2000) postulated that sym-
plekin could be an assembly/scaffolding protein, acting
as a platform for the binding of the polyadenylation
machinery. Our results support this hypothesis, with
symplekin interacting with both CPSF and CPEB before
and during cytoplasmic polyadenylation. Interestingly,
for both nuclear and cytoplasmic polyadenylation, sym-
plekin appears to interact with two RNA binding moie-
ties: CPSF and CstF in the nucleus, and CPSF and CPEB
in the cytoplasm. This raises the possibility that at least
one symplekin function could be to increase the weak
RNA binding specificity of CPSF 160 to AAUAAA (Lutz
et al., 1996) by bridging it to another specificity factor,
e.g., CPEB or CstF.
The activity of poly(A) polymerase in the cytoplasm
of maturing oocytes has been enigmatic. During this
M phase progression, conventional poly(A) polymerase,
which is both nuclear and cytoplasmic in oocytes, un-
dergoes multiple maturation promoting factor (MPF, a
heterodimer of the kinase cdk1 and cyclin B)-directed
phosphorylation events (Ballantyne et al., 1995) that in-
Figure 6. Interactions within the Cytoplasmic Polyadenylation activate the enzyme (Colgan et al., 1996). If conventional
Complex poly(A) polymerase is inactivated as oocytes mature,
(A) Recombinant xGLD-2 or GST, both S-tagged and bound to S then what enzyme drives cytoplasmic polyadenylation
protein-agarose beads, were incubated with 35S-methionine-labeled
at this time? Gebauer and Richter (1995) identified anCPEB, symplekin, or CPSF160. The beads were washed and the
alternatively processed form of poly(A) polymeraseproteins eluted in buffer containing 150 mM KCl, 250 mM KCl, or
mRNA in oocytes that encode a form of the protein thatSDS. The proteins were resolved by 8% SDS-PAGE and visualized
by phosphorimager analysis. Ten percent of the input of all three lacks the major MPF phosphorylation sites. While this
labeled proteins was analyzed in lane 1. protein is active in vitro, immunological approaches to
(B) S-tagged xGLD-2 bound to S protein-agarose was incubated detect it in oocytes have not been successful. The recent
with 35S-methionine-labeled CPEB proteins containing S174A/ identification of Cid 1 and Cid 13 (Read et al., 2002;
S180A (AA) or S174D/S180D (DD) double mutations. The beads were
Saitoh et al., 2002) as well as GLD-2 (Wang et al., 2002)washed, and the bound proteins were analyzed as described above.
as members of the DNA polymerase -like superfamily(C) Model of interactions among CPEB, CPSF, symplekin, and
of nucleotidyltransferases (Aravind and Koonin, 1999)xGLD-2. P refers to phosphorylated CPEB serine 174.
that reside in the cytoplasm and have poly(A) polymer-
ase activity suggested that a similar enzyme could drive
polyadenylation during oocyte maturation. Indeed, weby a reticulocyte kinase). These results suggest that
have now shown that the Xenopus homolog of GLD-2CPEB serine 174 phosphorylation helps secure xGLD-2
(xGLD-2) is associated with the cytoplasmic polyadenyl-to the cytoplasmic polyadenylation complex.
ation complex and catalyzes polyadenylation in recon-
stituted extracts following symplekin-mediated depletion.
Discussion Like other members of the GLD-2 family (Kwak et
al., 2004), xGLD-2 lacks any recognizable RNA binding
In this study, we define two new proteins that are essen- motif, indicating that it may have to associate with other
tial for cytoplasmic polyadenylation: symplekin and factors that help it find the mRNA 3 end. A yeast two-
XGLD-2. Symplekin binds to both CPEB and CPSF and hybrid screen with C. elegans GLD-2 identified a worm
may help keep these factors in close proximity in oo- homolog of the Drosophila Bicaudal-C protein, GLD-3,
cytes prior to the phosphorylation of CPEB, which acti- as an interacting factor (Wang et al., 2002). GLD-3 is a
vates the cytoplasmic polyadenylation machinery. Al- KH domain-containing RNA binding protein that may
though a role for “conventional” poly(A) polymerase lend mRNA specificity to the polyadenylation reaction.
cannot be ruled out, XGLD-2 appears to be the main In Xenopus, it appears that interaction with CPEB and
polymerase that drives cytoplasmic polyadenylation. It CPSF is an important element in recruiting xGLD-2 to
is anchored to the polyadenylation complex even in the CPE-containing mRNA (Figure 6).
The observation that recombinant xGLD-2 stimulatesabsence of ongoing polyadenylation through interac-
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some polyadenylation of CPE-lacking RNA in extracts CPSF160 plays a very similar role with xGLD-2 in cyto-
suggests that this polymerase is normally a limiting com- plasmic polyadenylation.
ponent in frog eggs. This polyadenylation is much less Finally, CPEB-mediated polyadenylation-induced trans-
robust when compared to CPE-containing RNA, proba- lation occurs not only during oocyte maturation but dur-
bly because xGLD-2 is unable to stably associate with ing cell cycle progression (Groisman et al., 2002) and
these RNAs due to a lack of CPEB and CPSF binding. In neuronal synaptic stimulation (Wu et al., 1998; Huang
the absence of excess xGLD-2 (i.e., an unsupplemented et al., 2002) as well. Based on this report, we posit
extract) the CPE-lacking RNA is not polyadenylated, that symplekin and GLD-2, like CPEB, are likely to be
probably because the small amount of endogenous pro- important for these processes. Indeed, both Cid 1 and
tein is bound to CPEB/CPSF and therefore is not avail- Cid 13 (Saitoh et al., 2002; Read et al., 2002) influence
able to polyadenylate CPE-lacking RNA. Because cell cycle progression in yeast, although these phenom-
excess xGLD-2 leads to a loss of polyadenylation speci- ena are not related to CPEB. In metazoans, the apparent
ficity, oocytes would probably contain only limiting assembly of factors on the symplekin scaffold suggests
amounts of the enzyme. Indeed, xGLD-2 is below the that this protein might be a useful hook to isolate entire
level of detection on Western blots of total oocyte (non- complexes involved in unique forms of cytoplasmic
yolk) protein; however, by enriching for the polyadenyla- polyadenylation, including specialized RNA substrates.
tion machinery through symplekin immunoprecipitation, For example, polyadenylation in mammalian neurons is
xGLD-2 is readily detected. stimulated by N-methyl-D-aspartate (NMDA) receptor
RNA that is added to an immunoprecipitated sym- activation (Huang et al., 2002), which is certainly not the
plekin-containing complex undergoes an amazingly ro- case during cell cycle progression. Perhaps neuronal
bust polyadenylation approaching nearly 1500 bases; cytoplasmic polyadenylation complexes contain ancil-
extracts, on the other hand, support polyadenylation up lary factors that uniquely allow them to respond to
to only one-tenth of that amount (Figure 5D). Not only do NMDA stimulation; such factors might be identified
these results demonstrate that symplekin is associated, through symplekin coimmunoprecipitation and mass
directly or indirectly, with all the factors that promote spectrometry. Factors involved in cytoplasmic polayde-
polyadenylation, they imply that eggs contain a factor nylation during the cell cycle could be identified in a
that associates with a growing poly(A) tail that limits its similar manner.
length. Poly(A) binding protein 2 (PABP2) accomplishes
this task for nuclear pre-mRNA polyadenylation (Wahle, Experimental Procedures
1995); we do not yet know what factor has this activity
Reagentsin the oocyte cytoplasm.
DNA constructs encoding the WT CPE-containing cyclin B1 3 UTRThe results presented here require us to revise our
or a corresponding CPE-lacking mutant have been described pre-
previous model for cytoplasmic polyadenylation (Men- viously (Stebbins-Boaz et al., 1996). The information-free RNA was
dez and Richter, 2001). Because CPEB, CPSF, sym- derived from the polylinker sequence of pBluescript SK digested
plekin, and xGLD-2 are all present in a complex prior to with Hind II and transcribed with T3 RNA polymerase. The Xenopus
symplekin ORF was amplified from a Xenopus IMAGE cDNA clonepolyadenylation, the recruitment of CPSF by CPEB, and
from Open Biosystems and cloned into the EcoRI (5) and XhoI (3)the recruitment of the polymerase by CPSF, to the RNA
sites of pBluescript SK, pET 30A and pET41A. Xenopus GLD-2no longer appears tenable. On the other hand, Mendez
was cloned from stage VI oocyte mRNA. Reverse transcription waset al. (2000a) showed that aurora A-catalyzed CPEB
primed with oligo dT, and xGLD-2 was amplified and cloned into
serine 174 phosphorylation stimulated an association pET 30A. Recombinant his-tagged CPEB, xGLD-2, and symplekin
with CPSF that resulted in polyadenylation. Moreover, were expressed in E. coli and purified on Ni-NTA (Qiagen) following
this CPEB phosphorylation stimulated polyadenylation the manufacturer’s recommendations. GST-symplekin and GST
(containing an S peptide) were purified on glutathione-Sepharosein vitro using purified CPEB, CPSF, and conventional
(Amersham Biosciences) and eluted with 10 mM reduced glutathi-poly(A) polymerase (Mendez et al., 2000b). We propose
one. Proteins were dialyzed against 100 mM KCl, 20 mM Tris (pHthat, even though symplekin bridges unphosphorylated
8), 10% glycerol, and 0.5 mM DTT and stored at 80C. CPSFCPEB and CPSF, phospho-CPEB undergoes a confor-
was partially purified from HeLa cell nuclear extract as previously
mational change such that its increased affinity for CPSF described (Ryan et al., 2002). Recombinant xGLD-2 was used to
activates xGLD-2, perhaps by helping juxtapose the raise antibodies in rabbits. Antibodies against CPEB and CPSF 100
polymerase and the 3 end of the mRNA. The apparent have been previously described (Hake and Richter, 1994; Mendez et
al., 2000b). Antibodies against symplekin (Sym-TJ-E150 from Maineincreased affinity of phospho-CPEB for xGLD-2 may
Biotechnology Services, Inc., and a-Sym from BD Biosciences) andhelp activate the polymerase as well. It is also possible
mos (Santa Cruz) were obtained commercially.that the activity of the polymerase is modified by cova-
lent (e.g., phosphorylation) or noncovalent (e.g., asso-
Oocytes and Injections
ciating with a factor) interactions. Indeed, canonical Oocytes were obtained as previously described (de Moor and Rich-
poly(A) polymerase activity is regulated by phosphoryla- ter, 1997). Stage VI oocytes were injected with a 50 nL solution
tion, as noted earlier, as well as through interactions containing Sym-TJ-E150 or control hybridoma supernatant and in-
with other proteins (Kim et al., 2003; Helmling et al., 2001; cubated for 16 hr at 22C. Noninjected and antibody-injected oo-
cytes (25 nL containing radiolabeled RNA probe) were incubated inKaufmann et al., 2004). We are attempting to identify
the presence or absence of 20 nM progesterone. When oocytesadditional components of the cytoplasmic polyadenyla-
in the noninjected group underwent germinal vesicle breakdowntion complex that could modify xGLD-2 activity. It is
(GVBD), all oocytes were collected for RNA analysis by denaturing
noteworthy that PAP, like xGLD-2, binds to CPSF160, polyacrylamide gel electrophoresis (PAGE). Identical experiments
and this interaction plays a significant role in targeting were carried out without the injection of radiolabeled RNA for moni-
PAP in nuclear AAUAAA-dependent polyadenylation toring protein synthesis. In other experiments, 50 nl of mRNA (0.5
g/l) encoding myc-tagged CPEB (Hake and Richter, 1994) was(Murthy and Manley, 1995). It is conceivable that
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